Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 1/20 | 0.72 |
| ▸ | NPC1 | O15118 | 1/20 | 0.72 |
| ▸ | RAB9A | P51151 | 1/20 | 0.72 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.72 |
| ▸ | DRD2 | P14416 | 1/20 | 0.51 |
| ▸ | DRD3 | P35462 | 1/20 | 0.51 |
| ▸ | SIGMAR1 | Q99720 | 1/20 | 0.48 |
| ▸ | DDB1 | Q16531 | 1/20 | 0.44 |
| ▸ | CRBN | Q96SW2 | 1/20 | 0.44 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.43 |
| ▸ | ROCK1 | Q13464 | 1/20 | 0.43 |
| ▸ | KDM1A | O60341 | 2/20 | 0.43 |
| ▸ | GSK3A | P49840 | 1/20 | 0.42 |
| ▸ | GSK3B | P49841 | 1/20 | 0.42 |
| ▸ | HTR2A | P28223 | 1/20 | 0.41 |
| ▸ | HTR2C | P28335 | 1/20 | 0.41 |
| ▸ | HTR2B | P41595 | 1/20 | 0.41 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6362778 | 0.88 | MEN1 (0.61) | MEN1NPC1RAB9AKMT2ADRD2 | |
| SCHEMBL8299963 | 0.84 | MEN1 (0.52) | MEN1NPC1RAB9AKMT2AKDM1A | |
| SCHEMBL610584 | 0.84 | NPC1 (1.00) | MEN1NPC1RAB9AKMT2ADRD2 | |
| SCHEMBL15448368 | 0.82 | DRD2 (0.55) | MEN1NPC1RAB9AKMT2ADRD2 | |
| SCHEMBL3577171 | 0.82 | MAPT (0.47) | MEN1NPC1RAB9AKMT2ADRD2 | |
| SCHEMBL182484 | 0.80 | RAB9A (0.45) | MEN1NPC1RAB9AKMT2ADRD2 | |
| SCHEMBL22349847 | 0.80 | DRD2 (0.54) | MEN1NPC1RAB9AKMT2ADRD2 | |
| SCHEMBL19297530 | 0.80 | RAB9A (0.45) | MEN1NPC1RAB9AKMT2ADRD2 | |
| SCHEMBL12362754 | 0.80 | RAB9A (0.45) | MEN1NPC1RAB9AKMT2ADRD2 | |
| SCHEMBL11659873 | 0.80 | DRD2 (0.54) | MEN1NPC1RAB9AKMT2ADRD2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 98 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-12565550-B2 | Polydiene rubbers with functionalized end groups | ARLANXEO DEUTSCHLAND GMBH (DE) | 2026-03-03 | — | — | US | disclosed |
| WO-2025242516-A1 | BRANCHED DIENE RUBBER | ARLANXEO DEUTSCHLAND GMBH (DE) | 2025-11-27 | — | — | WO | disclosed |
| EP-4126562-B1 | POLYDIENE RUBBERS WITH FUNCTIONALIZED END GROUPS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2025-08-13 | — | — | EP | disclosed |
| US-12371514-B2 | 1-amino-3-(oxyalkylalkoxysilyl)-2-propanol-terminated diene rubbers | ARLANXEO DEUTSCHLAND GMBH (DE) | 2025-07-29 | — | — | US | disclosed |
| US-20250115702-A1 | MODIFIED DIENE RUBBERS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2025-04-10 | — | — | US | disclosed |
| EP-3999552-B1 | CARBOXYTERMINATED DIENE RUBBERS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2025-03-05 | — | — | EP | disclosed |
| US-20250043041-A1 | FUNCTIONALIZED DIENE RUBBERS PREPARED WITH UNSATURATED SILOXANE-BASED COUPLING AGENTS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2025-02-06 | — | — | US | disclosed |
| US-20250043040-A1 | DIENE RUBBERS PREPARED WITH UNSATURATED SILOXANE-BASED COUPLING AGENTS | ARLANXEO DEUTSCHLAND GMBH (DE) | 2025-02-06 | — | — | US | disclosed |
| EP-4476284-A1 | MODIFIED DIENE RUBBERS | ARLANXEO Deutschland GmbH (DE) | 2024-12-18 | — | — | EP | disclosed |
| EP-4444762-A1 | FUNCTIONALIZED DIENE RUBBERS PREPARED WITH UNSATURATED SILOXANE-BASED COUPLING AGENTS | ARLANXEO Deutschland GmbH (DE) | 2024-10-16 | — | — | EP | disclosed |
| US-7166603-B2 | Dihydropyrimidone inhibitors of calcium channel function | BRISTOL-MYERS SQUIBB CO. (US) | 2007-01-23 | — | — | US | disclosed |
| WO-2006114371-A1 | NOVEL COMPOUNDS FOR TREATING INFLAMMATORY DISEASES | BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) | 2006-11-02 | — | — | WO | disclosed |
| US-6942948-B2 | Nonaqueous electrolyte solution and secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2005-09-13 | — | — | US | disclosed |
| CN-1215595-C | Nonaqueous electrolyte and secondary battery using the same | MITSUBISHI CHEM CORP (JP) | 2005-08-17 | — | — | CN | disclosed |
| CN-1465117-A | Nonaqueous electrolyte and secondary battery using the same | MITSUBISHI CHEM CORP (JP) | 2003-12-31 | — | — | CN | disclosed |
| US-20030165733-A1 | Nonaqueous electrolyte solution and secondary battery employing the same | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-09-04 | — | — | US | disclosed |
| EP-1317013-A1 | NON-AQUEOUS ELECTROLYTE AND SECONDARY CELL USING THE SAME | MITSUBISHI CHEMICAL CORPORATION (JP) | 2003-06-04 | — | — | EP | disclosed |
| EP-0921800-A4 | SUBSTITUTED BIPHENYL ISOXAZOLE SULFONAMIDES | BRISTOL MYERS SQUIBB CO (US) | 2000-12-06 | — | — | EP | disclosed |
| EP-0921800-A1 | SUBSTITUTED BIPHENYL ISOXAZOLE SULFONAMIDES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1999-06-16 | — | — | EP | disclosed |
| WO-1997029748-A1 | SUBSTITUTED BIPHENYL ISOXAZOLE SULFONAMIDES | BRISTOL-MYERS SQUIBB COMPANY (US) | 1997-08-21 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12565550-B2 | Polydiene rubbers with functionalized end groups | MSR1, NR1H3, NR1H2 | MEN1 3818/4885NPC1 2152/4885RAB9A 3555/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.